Dianthus Therapeutics, Inc. (DNTH)

NASDAQ: DNTH · Real-Time Price · USD

36.47

-0.69 (-1.86%)

Sep 15, 2025, 3:36 PM EDT - Market open

Dianthus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 15, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,411	645	154	-	-
Market Cap Growth	-21.12%	318.69%	-	-	-
Enterprise Value	1,102	364	-35	-	-
Last Close Price	37.16	21.80	10.40	-	-
PS Ratio	270.39	103.48	54.53	-	-
PB Ratio	3.95	1.83	0.91	-	-
P/TBV Ratio	4.65	1.83	0.91	-	-
EV/Sales Ratio	227.11	58.45	-	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.01	-
Asset Turnover	0.01	0.02	0.02	0.14	-
Quick Ratio	12.81	14.96	18.09	9.86	1.70
Current Ratio	13.12	15.22	18.43	9.97	1.75
Return on Equity (ROE)	-34.71%	-32.60%	-35.92%	-73.25%	-
Return on Assets (ROA)	-23.37%	-23.01%	-22.94%	-40.12%	-
Return on Capital (ROIC)	-24.49%	-24.33%	-24.69%	-47.27%	-
Earnings Yield	-8.14%	-13.17%	-28.26%	-	-
FCF Yield	-7.12%	-12.13%	-23.99%	-	-
Buyback Yield / Dilution	-71.34%	-546.44%	-489.48%	78.17%	-

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q